Macleods Pharmaceuticals Ltd. (India) holds 133 active US FDA Type II Drug Master Files and 1 inactive, has DMF or CEP filings on record for 40 active ingredients and is linked to 5 FDA-registered manufacturing sites. 25 FDA enforcement records are linked to it.

Sources: FDA Drug Master File list, EDQM certification database, FDA establishment registrations and enforcement records. How we read these records

Cite as: PharmaTek, “Macleods Pharmaceuticals Ltd.: DMF, site and FDA enforcement record”, record as of 16 Nov 2026, pharmatek.co.uk/directory/macleods-pharmaceuticals-ltd

Overview

Macleods Pharmaceuticals Ltd. is a private pharmaceutical company headquartered in India, known for its focus on the development, manufacture, and commercialization of a wide range of pharmaceutical products. The company is a significant player in both Indian and global markets, providing quality and affordable medicines across various therapeutic areas.

Core services & business areas

Pharmaceutical ManufacturingQuality AssuranceResearch and DevelopmentRegulatory Affairs

Therapeutic areas

Active ingredients with DMF or CEP filings

Substances for which Macleods Pharmaceuticals Ltd. holds, or has held, a US FDA Drug Master File or an EU CEP. A filing is not proof of current supply. Open any ingredient to see all its holders, CAS number and product patent dates.

API / Drug Master Files

Macleods Pharmaceuticals Ltd. holds 133 active (134 total) FDA Type II Drug Master Files. A Type II DMF is filed with the FDA to support an active ingredient in drug applications; an active filing can be referenced but is not proof of current supply, and inactive filings are historical.

  • PROMETHAZINE HYDROCHLORIDEActive2026-09-29
  • FEZOLINETANTActive2026-09-02
  • VONOPRAZAN FUMARATEActive2026-08-31
  • PIRTOBRUTINIBActive2026-07-27
  • PALBOCICLIBActive2026-03-31
  • DEUCRAVACITINIBActive2026-03-31
  • LIOTHYRONINE SODIUM USPActive2025-09-23
  • POMALIDOMIDEActive2025-04-08
  • ATOGEPANTActive2025-03-13
  • ENZALUTAMIDEActive2025-02-19
  • RIFAXIMINActive2025-01-04
  • FINERENONEActive2024-09-27
  • VILOXAZINE HYDROCHLORIDEActive2024-09-27
  • MIRABEGRONActive2024-04-04
  • PROPRANOLOL HYDROCHLORIDE USPActive2024-04-01
  • URSODIOL USPActive2024-03-31
  • NINTEDANIB ESYLATEActive2024-03-31
  • 1-DOCOSANOLActive2023-12-20
  • TICAGRELORActive2023-09-26
  • TOFACITINIB CITRATEActive2023-09-26
  • APIXABANActive2023-04-10
  • DICLOFENAC SODIUM USPActive2023-04-10
  • PALIPERIDONE USPActive2022-04-12
  • DAPSONE USPActive2021-12-29
  • SODIUM ZIRCONIUM CYCLOSILICATEActive2021-12-07
  • MEXILETINE HYDROCHLORIDE USPActive2021-10-28
  • TAMSULOSIN HYDROCHLORIDE USPActive2021-07-03
  • RIFAPENTINEActive2021-06-30
  • CRISABOROLEActive2020-09-19
  • LABETALOL HYDROCHLORIDE USPActive2020-01-27
  • VARENICLINE TARTRATEActive2019-09-27
  • TENOFOVIR ALAFENAMIDE FUMARATEActive2019-06-29
  • HYDROCHLOROTHIAZIDE USPActive2019-06-29
  • TRAMADOL HYDROCHLORIDE USPActive2019-04-06
  • DAPSONEActive2019-01-16
  • BREXPIPRAZOLEActive2019-01-14
  • SACUBITRIL/VALSARTANActive2019-01-10
  • METOPROLOL SUCCINATEActive2019-01-07
  • METFORMIN HYDROCHLORIDEActive2018-09-29
  • LOSARTAN POTASSIUMActive2018-09-29
  • LINAGLIPTINActive2018-04-05
  • PIRFENIDONEActive2018-04-03
  • TENOFOVIR ALAFENAMIDE FUMARATEActive2018-03-27
  • EMPAGLIFLOZINActive2018-01-29
  • EFINACONAZOLEActive2018-01-09
  • CHLORTHALIDONEActive2017-11-24
  • APREMILASTActive2017-10-18
  • LURASIDONE HYDROCHLORIDEActive2017-09-27
  • DAPAGLIFLOZIN PREMIXActive2017-08-02
  • RIVAROXABANActive2017-07-03

Showing the 50 most relevant of 134 Drug Master Files (active first). The full list is in the FDA DMF list.

Registered manufacturing sites (5)

Physical sites registered with the US FDA and resolved to Macleods Pharmaceuticals Ltd., with any EU/UK GMP documents matched to each site. Headquarters and manufacturing locations can differ.

FDA compliance signals

25 FDA enforcement records linked to this company.

  • recall — Class III2026-09-30

    Failed Impurities/Degradation Specifications:Organic and unspecified impurities above specification.

  • recall — Class III2025-07-16

    Presence of Foreign Substance- Black hair strand found attached to a tablet in a sealed bottle.

  • recall — Class III2025-06-18

    Presence of a foreign substance: black hair found embedded in tablet.

  • recall — Class II2024-12-25

    Failed Impurities/Degradation Specifications

  • 4832024-08-23

    Investigations of discrepancies, failures

  • 4832024-08-23

    Complaint Handling Procedure

  • 4832024-08-23

    Procedures not in writing, fully followed

  • 4832023-10-20

    Written procedures not established/followed

  • 4832023-10-20

    Valid stability test methods

  • 4832023-10-20

    Computer control of master formula records

  • 4832023-10-20

    Procedures for non-sterile drug products

  • 4832023-10-20

    Contamination, chemical or physical change, deterioration

  • 4832023-10-20

    In-process materials specifications

  • 4832023-10-20

    Scientifically sound laboratory controls

  • 4832023-10-20

    Quality control unit review of records

  • 4832023-05-26

    Equipment Design, Size and Location

  • 4832017-11-24

    Control procedures to monitor and validate performance

  • 4832017-11-24

    Absence of Written Procedures

  • 4832017-11-24

    Investigations of discrepancies, failures

  • 4832017-11-24

    Complete Test Data

  • 4832017-11-24

    Representative Samples

  • 4832017-11-24

    Annual visual exams of drug products

  • 4832017-11-24

    Training--operations, GMPs, written procedures

  • 4832017-11-24

    Scientifically sound laboratory controls

  • 4832017-11-24

    Complaint Handling Procedure

For suppliers

Is this Macleods Pharmaceuticals Ltd.?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.

Need suppliers found and checked?

The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.